Pfizer (PFE) Stock Analysis: AI Score & Alternative Data
PFE alt-data: headcount climbing, business outlook lagging
Is Pfizer a buy right now? The alternative data says hold. This PFE stock analysis is built on the 25+ alternative data signals AltIndex tracks on Pfizer every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 42/100: a Hold. The stock trades at $26.79 with a $153B market cap.
The bullish side of the 90-day ledger: headcount (according to LinkedIn) up 5.3% to 109K employees, and sentiment up 16.9% to 83/100. The drag: just 49% of employees report a positive business outlook, and Reddit mentions down 75.0% to 2 a day. That tension is what keeps the score mid-range.
PFE’s broader alt-data profile also covers job postings (871 open roles), web traffic (1.7M monthly visits), quarterly revenue ($15.0B), and Facebook followers (565K). Every signal links to its own page with full history, the PFE technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on PFE is just below.
Pfizer AI Stock Analysis
Pfizer Inc. is an American multinational pharmaceutical corporation. Established in 1849 and headquartered in New York City, Pfizer is one of the world's largest pharmaceutical companies, renowned for its innovative medications and vaccines.
Analysis generated August 1, 2026.
Recent Pfizer Stock Alerts
|
Pfizer | August 13 Ro Khanna (member of U.S. congress) is buying shares |
|
Pfizer | August 10 Michael Rulli (member of U.S. congress) is selling shares |
|
Pfizer | August 8 Insider Alert: DAMICO JENNIFER B. is selling shares |
|
Pfizer | August 7 Insider Alert: Buckley Mortimer J is buying shares |
Pfizer Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 1.7M | 3.1% | |
| Job Posts | 871 | 4.1% | |
| LinkedIn Employees | 109K | 5.3% | |
| Google Trends | 22 | 56.0% | |
| Wikipedia Views | 593 | 12.1% | |
| Employee Recommend | 69 | 0% | |
| Business Outlook | 49 | 0% | |
| Lobbying Cost | $593K | 0% | |
| Sentiment | 83 | 16.9% | |
| Reddit Mentions | 2 | 75.0% | |
| X Mentions | 27 | 86.5% | |
| Stocktwits Mentions | 259 | 14.5% | |
| News Mentions | 15 | 650.0% | |
| Stocktwits Subscribers | 106K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 470K | 0% | |
| Instagram Followers | 125K | 0% | |
| Youtube Subscribers | 15 | 0% | |
| Facebook Followers | 565K | 0% | |
| Facebook Engagement | 123 | 44.7% |
About Pfizer (PFE)
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
| Price | $26.79 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $153B |
| Year Range | $22 – $28 |
| Dividend Yield | 0% |
| PE Ratio | 34.8 |
| Analyst Rating | 38% buy |
| Industry | Drug Manufacturers |
Latest Pfizer News
View more → |
Closed Pfizer biopharma facility in Everett gets a new lease on lifeAugust 14 - GeekWire |
 |
Pfizer’s former chemistry whiz debuts Khartis Therapeutics with $95M for thyroid eye disease pillAugust 14 - Biztoc.com |
 |
Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get moneyAugust 13 - Biztoc.com |
 |
Former Pfizer Toxicologist’s Book Alleges COVID-19 Shots Were Sold Without Proper Safety TestingAugust 11 - Naturalnews.com |
 |
“The Vaccine Mafia”: Book by Former Pfizer Toxicologist Exposes the Crime of the CenturyAugust 11 - Globalresearch.ca |
Pfizer Earnings & Financial Performance
View all earnings →Pfizer Insider Trading Activity
View all →| DAMICO JENNIFER B. filed to sell 28,611 shares at $0.0. Aug 5 '26 |
| Buckley Mortimer J filed to sell 37,632 shares at $0.0. Aug 5 '26 |
| BLAYLOCK RONALD E filed to sell 66,938 shares at $0.0. Aug 5 '26 |
| DAMICO JENNIFER B. filed to sell 31,397 shares at $0.0. Jun 9 '26 |
| DAMICO JENNIFER B. filed to sell 11,850 shares at $0.0. Mar 4 '25 |
Pfizer Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Aug 12, 26 | Buy | $8K+ |
| Michael Rulli |
Aug 10, 26 | Sell | $8K+ |
| Tommy Tuberville |
Jul 16, 26 | Sell | $33K+ |
| Gilbert Cisneros |
Mar 10, 26 | Buy | $8K+ |
| James French Hill |
Jan 26, 26 | Sell | $175K+ |
Stocks Similar to Pfizer
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Bristol-Myers SquibbBMY |
$63.83 1.3% | $132B | 55 |
 |
SanofiSNY |
$43.72 0.1% | $105B | 49 |
 |
Novo NordiskNVO |
$45.89 1.8% | $205B | 53 |
 |
AstrazenecaAZN |
$156.45 0.5% | $244B | 50 |
 |
Teva PharmaceuticalTEVA |
$36.77 0.7% | $43B | 51 |
Explore Pfizer Data
Frequently Asked Questions: Pfizer (PFE)
Pfizer has an AltIndex AI Score of 42/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
42/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Pfizer (PFE) stock is $26.79 with a market cap of $153B.
As of today, Pfizer’s PE (Price to Earnings) ratio is 34.8.
View the latest Pfizer insider transactions to see recent buying and selling activity by company executives and directors.
Check the Pfizer congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The PFE stock price chart above shows Pfizer’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Pfizer technical analysis for RSI, moving averages, and more.
See the stocks similar to Pfizer section on this page for companies in the same industry ranked by market cap and AI Score.
